| Financial Year |
March 31 2023 |
| Monetary Funds |
1,404,433,086.35 |
| Held-for-trading Financial Assets |
275,575,864.04 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,402,484,391.62 |
| Advances to Suppliers |
107,679,647.07 |
| Other Receivables |
119,516,574.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,982,860,271.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
107,023,277.51 |
| Total Current Assets |
5,607,508,474.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
85,321,628.16 |
| Investment Properties |
96,795,853.90 |
| Fixed Assetes |
4,592,953,479.28 |
| Under-construction Projects |
994,399,348.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
727,567,200.63 |
| R&D expenses |
-- |
| Goodwill |
27,906,888.45 |
| Long-Term Deferred and Prepaid Expenses |
8,280,238.20 |
| Deferred Income Tax Assets |
95,691,881.22 |
| Other Non-Current Assets |
127,891,775.92 |
| Sub-Total of Non-Current Assets |
6,875,763,833.60 |
| Total Assets |
12,483,272,307.95 |
| Short-Term Loans |
50,063,400.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,495,410.12 |
| Accounts Payable |
1,018,132,871.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
95,221,930.87 |
| Taxes Payable |
66,166,306.15 |
| Interest Payable |
-- |
| Dividend Payable |
29,971.18 |
| Other payables |
554,193,577.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
635,983,069.66 |
| Other Current Liabilities |
3,508,586.60 |
| Sub-Total of Current Liabilities |
2,481,282,016.18 |
| Long-term Loans |
115,116,700.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,519,377.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
178,740,326.44 |
| Total Liabilities |
2,660,022,342.62 |
| Paid-In Capital(Or Share Stock) |
965,128,000.00 |
| Capital Surplus |
1,968,119,318.11 |
| Surplus Reserve |
1,586,460,146.22 |
| LESS:Treasury Stock |
57,692,375.00 |
| Undistributed Profits |
4,943,651,451.49 |
| Minority Stockholder's Interest |
421,648,907.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,401,601,058.23 |
| Owner's Equity（Stockholder's Equity） |
9,823,249,965.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,483,272,307.95 |
